Skip to content
PIL Logo

octaplex

Last Updated on eMC 03-Jul-2015 View document  | Octapharma Limited Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 03-Jul-2015 and displayed until Current

Reasons for adding or updating:

  • Change to section 6 - date of revision
  • Change to information for healthcare professionals
  • Improved presentation of PIL

Updated on 13-May-2014 and displayed until 03-Jul-2015

Reasons for adding or updating:

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 4 - how to report a side effect
  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - date of revision
  • Change to information for healthcare professionals

Updated on 09-Jun-2011 and displayed until 13-May-2014

Reasons for adding or updating:

  • Change to date of revision

Updated on 22-May-2009 and displayed until 09-Jun-2011

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Octapharma Limited

Company image
Address

The Zenith Building, 26 Spring Gardens, Manchester, Lancashire, M2 1AB

Fax

+44 (0)161 837 3799

Medical Information e-mail
Telephone

+44 (0)161 837 3770

Medical Information Direct Line

0845 1300 522

Medical Information Fax

+44 (0)161 837 3799

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

human coagulation factor II, human coagulation factor IX, human coagulation factor VII, human coagulation factor X, protein c, protein s

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue